The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has said on Thursday that people should still get the Oxford vaccine as Denmark’s concerns are “not confirmed.”
Today the Danish Health Minister said that they are investigating a report of a death after a person died with a blood clot after having the AstraZeneca jab.
However, it is not known if there is any connection to patient having the Oxford/AstraZeneca jab and dying of the blood clot.
Denmark’s Health Minister, Magnus Heunicke wrote on Twitter, “The health authorities have, due to precautionary measures, suspended vaccination with AstraZeneca following a signal of a possible serious side effect in the form of fatal blood clots.
“It is currently not possible to conclude whether there is a connection. We act early, it needs to be thoroughly investigated.”
The MHRA said in a statement today, “This is a precautionary measure by the Danish authorities.
“It has not been confirmed that the report of a blood clot was caused by the AstraZeneca COVID-19 Vaccine.
“People should still go and get their COVID-19 vaccine when asked to do so.”
In a statement, the EMA added, “The information available so far indicates that the number of thromboembolic events in vaccinated people is no higher than that seen in the general population.
“As of March 9, 2021, 22 cases of thromboembolic events had been reported among the 3 million people vaccinated with COVID-19 Vaccine AstraZeneca in the European Economic Area.”
An AstraZeneca spokesperson said, “Patient safety is the highest priority for AstraZeneca. Regulators have clear and stringent efficacy and safety standards for the approval of any new medicine, and that includes COVID-19 Vaccine AstraZeneca.
“The safety of the vaccine has been extensively studied in Phase III clinical trials and peer-reviewed data confirms the vaccine has been generally well tolerated.”
Leave a Comment